RKI-1447 is a selective small molecule inhibitor targeting ROCK1 and ROCK2 kinases. It demonstrates anti-invasive and anti-tumor properties, making it a valuable research tool for studying cancer cell migration, metastasis, and tumor progression in both cellular and animal models.